PUBLISHER: The Business Research Company | PRODUCT CODE: 1978484
PUBLISHER: The Business Research Company | PRODUCT CODE: 1978484
Bioimaging technologies encompass a wide range of techniques used to visualize and analyze biological structures and processes within living organisms or biological samples. These technologies are essential in research and medical applications, enabling scientists and clinicians to monitor biological activity in real time or at specific stages without invasive procedures.
The main types of bioimaging technologies include confocal microscopy, super-resolution microscopy, electron microscopy, and multiphoton microscopy. Confocal microscopy is an advanced optical imaging method that employs point illumination and a spatial pinhole to eliminate out-of-focus light, producing high-resolution, high-contrast images of thick specimens. These technologies can analyze various sample types, including live cells, fixed cells, tissues, and three-dimensional (3D) samples, using contrast agents such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), nuclear medicine, and optical agents. Applications span oncology, cardiology, neurology, orthopedics, and other medical fields, with primary end users including hospitals, diagnostic imaging centers, research institutes, and related organizations.
Tariffs have affected the bio imaging technologies market by increasing the cost of imported imaging equipment, optical components, electronic sensors, and diagnostic hardware. These higher equipment costs have impacted hospitals, diagnostic centers, and research institutes, particularly in North America and Europe. Rising capital expenditure has slowed technology upgrades. Supply chain disruptions have also delayed equipment procurement. However, tariffs have encouraged domestic
The bio imaging technologies market research report is one of a series of new reports from The Business Research Company that provides bio imaging technologies market statistics, including bio imaging technologies industry global market size, regional shares, competitors with a bio imaging technologies market share, detailed bio imaging technologies market segments, market trends and opportunities, and any further data you may need to thrive in the bio imaging technologies industry. This bio imaging technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bio imaging technologies market size has grown strongly in recent years. It will grow from $7.14 billion in 2025 to $7.8 billion in 2026 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growth in biomedical research funding, expansion of clinical diagnostic imaging usage, rising prevalence of chronic diseases, adoption of advanced microscopy technologies, increased demand for early disease detection.
The bio imaging technologies market size is expected to see strong growth in the next few years. It will grow to $11 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to expansion of precision medicine adoption, rising demand for molecular imaging tools, growth in AI driven diagnostic platforms, increasing investment in healthcare infrastructure, integration of advanced imaging analytics. Major trends in the forecast period include high resolution imaging system development, AI assisted image analysis integration, non invasive diagnostic imaging expansion, real time cellular imaging tools, advanced contrast agent innovation.
The growing demand for diagnostic procedures is anticipated to drive the expansion of the bio imaging technologies market in the coming years. Diagnostic procedures include medical tests and methods such as imaging scans, biopsies, and laboratory analyses that are used to identify, monitor, and assess diseases or health conditions. The increase in diagnostic procedures is primarily attributed to the rising prevalence of chronic diseases, which necessitate frequent and precise testing for early detection, ongoing monitoring, and effective management of patient health outcomes. Bio imaging technologies support diagnostic procedures by offering detailed visualization of internal organs and tissues, allowing for accurate disease identification and tracking. These technologies facilitate early diagnosis through advanced imaging techniques, thereby enhancing treatment planning and improving overall patient outcomes. For example, in November 2023, according to the National Health Service, a UK-based government department, the number of imaging tests conducted in England reached 45.0 million in the year ending March 2023, representing a 2.2% increase from 44.0 million in 2022. As a result, the rising demand for diagnostic procedures is contributing to the growth of the bio imaging technologies market.
Companies in the bioimaging sector are increasingly developing technologies that enable rapid, low-impact imaging. Spinning disk confocal microscopy, a fluorescence-based technique, scans samples using a rotating disk with multiple pinholes, generating high-resolution 3D images of live cells while minimizing phototoxicity. In May 2025, Japan's Evident Co. Ltd. introduced the IXplore IX85 SpinXL and SpinSR microscopes for live-cell imaging. The SpinXL, incorporating CrestOptics X-light technology, provides a 26.5 mm field of view, imaging speeds up to 498 frames per second, and gentle NIR illumination for capturing large cellular areas. The SpinSR, utilizing Yokogawa CSU-W1 technology, delivers super-resolution imaging down to 120 nm and employs Trusight SR algorithms for detailed 3D analyses. Both systems support volumetric reconstruction with silicone gel pad objectives, offering researchers precise insights into biological structures.
In January 2025, Quanterix Corporation, a U.S.-based biotechnology company, acquired Akoya Biosciences Inc., a U.S.-based bioimaging firm, for an undisclosed amount. The acquisition is intended to provide a fully integrated solution for detecting protein biomarkers in blood and tissue, broaden Quanterix's footprint in neurology, oncology, and immunology, and improve profitability through operational efficiencies and cross-selling opportunities.
Major companies operating in the bio imaging technologies market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Konica Minolta Inc., Agilent Technologies Inc., Keyence Corporation, Olympus Corporation, Nikon Corporation, Hologic Inc., Shimadzu Corporation, Bruker Corporation, Hamamatsu Photonics K.K., Carestream Health Inc., Esaote S.p.A., Canon Medical Systems Corporation, Carl Zeiss Meditec AG, Applied Spectral Imaging, MARS Bioimaging Limited
North America was the largest region in the bio imaging technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio imaging technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bio imaging technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bio imaging technologies market consists of revenues earned by entities by providing services such as contract imaging for clinical trials and drug development, centralized image analysis and core lab services, education and training programs, digital image processing, and quality assurance. The market value includes the value of related goods sold by the service provider or included within the service offering. The bio imaging technologies market also includes sales of image analysis software, AI-powered platforms, whole-slide imaging systems, fluorescent dyes, contrast agents, radiopharmaceuticals, probe-based endomicroscopy tools, and hyperspectral imaging microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bio Imaging Technologies Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses bio imaging technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bio imaging technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bio imaging technologies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.